Guardant Health dips after unveiling $500 mln convertible offering
** Shares of precision oncology firm Guardant Health GH.O fall 2.6% to $150.74 in extended trading as it looks to raise capital
** Palo Alto, California-based GH offering privately $500 mln convertible bonds (CBs) due May 15, 2032
** Co expects to use net offering proceeds to repurchase a portion of its 0% CBs due 2027, remainder for general corp purposes, including potential acquisitions
** Also, GH intends to use some proceeds to fund cost of capped calls, transactions employed to mitigate potential dilution
** GH has about $21 bln market cap
** Stock closed down 0.4% at $154.78 on Weds, trimming YTD gain to 51.5%
** 26 of 28 analysts rate the stock "strong buy" or "buy", 2 "hold"; median PT is $200, per LSEG data